Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

US expansion update

6 Jan 2023 07:00

RNS Number : 8680L
Omega Diagnostics Group PLC
06 January 2023
 

OMEGA DIAGNOSTICS GROUP PLC

("Omega", the "Company" or the "Group")

 

US expansion update

 

Maiden US Laboratory FoodPrint® installation,

Appointment of US importer for FoodPrint® and

First PO from US CLIA certified Lab heralds start of US expansion

 

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has now received the maiden purchase order ('PO') for its FoodPrint® system from a CLIA certified ('Clinical Laboratory Improvement Amendments') laboratory in the United States, and has appointed a new US importer for FoodPrint® kits.

 

Using a small finger prick of blood, the FoodPrint® test can quickly identify an individual's unique food sensitivity reactions, allowing the patient to adjust and plan to a new diet and address IgG-mediated food sensitivities. FoodPrint® analyses up to 222 foods for IgG antibodies and is trusted by more than 150 laboratories worldwide, to help fast track a guided elimination diet allowing a more focused and actionable result for practitioners and their patients.

 

The Board expects installation at the laboratory to commence later this month and after a period of validation and gaining necessary approvals, the processing of tests to begin later this quarter. As well as being CLIA certified, the laboratory receiving the system is also College of American Pathologists accredited and specialises in providing functional tests for both consumers and healthcare practitioners.

 

Omega has also secured an importer for FoodPrint® kits into the USA. The importer will import kits for the CLIA laboratory as well as for Omega's own direct channels in future.

 

Although the value of this initial PO is circa £50,000, the US market is a key area of focus for Omega's growth strategy and this installation will be the first in the US market in over seven years, representing the beginning of Omega's planned expansion into the USA.

 

Jag Grewal, CEO of Omega Diagnostics, said: "The US is the single largest market for food sensitivity testing globally, with an ever-increasing demand for personalised medicine, and is a focus area for our growth plans. This installation reflects a key milestone in our expansion plans, the receiving laboratory is ideally placed to commercialise FoodPrint® in the US market as they are already providing a range of other functional tests. The appointment of the US importer will act as a foundation for our expansion into the region.

 

"Once the system has been commissioned, we plan to collaborate closely with our laboratory partner to ensure FoodPrint® is promoted effectively through their existing healthcare practitioner and direct to consumer channels."

 

 

Contacts: 

Omega Diagnostics Group PLC 

www.omegadx.com

Jag Grewal, Chief Executive Officer 

via Walbrook PR

Chris Lea, Chief Financial Officer

finnCap Ltd  

Tel: 020 7220 0500

Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)

Alice Lane/Charlotte Sutcliffe (ECM)

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Applegarth

Mob: 07584 391 303

Sam Allen

Mob: 07502 558 258

 

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

www.omegadx.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBAMLTMTTMBAJ
Date   Source Headline
12th Nov 202010:04 amRNSResponse to media comment
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
11th Nov 20207:00 amRNSInvestor Presentation - Q&A update
10th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 202011:05 amRNSSecond Price Monitoring Extn
10th Nov 202011:01 amRNSPrice Monitoring Extension
9th Nov 20202:05 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
9th Nov 202010:45 amRNSExercise of Options and Total Voting Rights
6th Nov 20209:00 amRNSExercise of Options and Total Voting Rights
3rd Nov 20207:00 amRNSChinese approval for Food Detective® test
30th Oct 20203:00 pmRNSExercise of Options and Total Voting Rights
29th Oct 20206:07 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSTrading update and notice of interim results
20th Oct 202011:00 amRNSExercise of Options and Total Voting Rights
20th Oct 20207:00 amRNSNotice of Trading Update and Investor Presentation
19th Oct 20207:00 amRNSUK-RTC contract for the Supply of Goods
14th Oct 20207:45 amRNSExercise of Options and Total Voting Rights
9th Oct 20204:15 pmRNSExercise of Options and Total Voting Rights
7th Oct 20207:00 amRNSUK Government contract for UK-RTC
6th Oct 20205:45 pmRNSHolding(s) in Company
6th Oct 20204:46 pmRNSUK Government contract for UK-RTC
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
2nd Oct 202012:00 pmRNSPreliminary report published by Ulster University
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSInvestor Presentation
24th Sep 20202:05 pmRNSSecond Price Monitoring Extn
24th Sep 20202:00 pmRNSPrice Monitoring Extension
15th Sep 20205:51 pmRNSExercise of Options and Total Voting Rights
15th Sep 20209:45 amRNSHolding(s) in Company
14th Sep 20204:41 pmRNSSecond Price Monitoring Extn
14th Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20202:05 pmRNSSecond Price Monitoring Extn
14th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSExercise of Options and Total Voting Rights
10th Sep 202010:11 amRNSHolding(s) in Company
7th Sep 20202:33 pmRNSStmnt re Share Price Movement
7th Sep 20207:00 amRNSCompletion of AbC-19 self-test usability study
3rd Sep 20207:00 amRNSCE-Mark for Mologic COVID-19 antibody test
1st Sep 20204:07 pmRNSExercise of Options and Total Voting Rights
28th Aug 20209:45 amRNSHolding(s) in Company
26th Aug 202011:20 amRNSResult of AGM
26th Aug 20207:00 amRNSExercise of Options and Total Voting Rights
24th Aug 20209:30 amRNSExercise of Options and Total Voting Rights
21st Aug 20207:00 amRNSWHO Prequalification received

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.